Steroid versus hyaluronic acid injections for hip arthritis

INTERVENTION: The participants will be randomly allocated to the following two groups: Group 1: Kenalog® (triamcinolone) 80 mg intraarticular injection into hip joint, used once on Day 1. Group 2: Hyaluronic acid 2 ml intraarticular injection into hip joint, used once on Day 1. CONDITION: Hip osteoarthritis ; Musculoskeletal Diseases ; Coxarthrosis [arthrosis of hip] PRIMARY OUTCOME: The following will be assessed at 6 weeks, 3 and 6 months:; 1. Visual Analogue Scale (VAS) for pain; 2. Oxford hip score for function SECONDARY OUTCOME: 1. Duration of pain relief; 2. Any complications, followed‐up for 6 months INCLUSION CRITERIA: 1. Clinical and radiological diagnosis of osteoarthritis (primary or secondary) 2. Both males and females, age over 16 years 3. Ability to understand the process and consent